Hemolytic and uremic syndrome in the child;Syndrome hémolytique et urémique chez l'enfant

Nephrologie et Therapeutique

Volumn 4, Issue 1, 2008, Pages 34-40

  Niaudet, Patrick ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

C3; Escherichia coli; Factor H; Factor I; Hemolytic uremic syndrome; MCP; Renal transplantation; Thrombotic microangiopathy

Indexed keywords

CYANOCOBALAMIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY FAILURE; ANURIA; BLOOD TRANSFUSION; CONGENITAL DISORDER; DIARRHEA; DISEASE ASSOCIATION; ESCHERICHIA COLI; FAMILIAL DISEASE; GENE MUTATION; HEMOLYTIC AND UREMIC SYNDROME; HEMOLYTIC ANEMIA; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROORGANISM; PEDIATRICS; PROGNOSIS; RECURRENT DISEASE; REGULATOR GENE; SHIGELLA DYSENTERIAE; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; UREMIA; VITAMIN METABOLISM;

CHILD; DIARRHEA; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MUTATION;

EID: 39049125539     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2007.07.006     Document Type: Short Survey

References (61)

1. Kaplan B.S., and Kaplan P. Hemolytic-uremic syndrome in families. In: Kaplan B.S., Trompeter R., and Moake J. (Eds). Hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura (1992), Dekker, New York 213-225
2. Renaud C., Niaudet P., Gagnadoux, Broyer M., and Habib R. Haemolytic-uraemic syndrome: prognostic features in children over three years of age. Pediatr Nephrol 9 (1995) 24-29
3. Kaplan B.S. Haemolytic-uremic syndrome with recurrent episodes: an important subset. Clin Nephrol 8 (1977) 495-498
4. Repetto H.A. Epidemic hemolytic-uremic syndrome in children. Kidney Int 52 (1997) 1708-1719
5. Andreoli S., Trachtman H., Acheson D., Siegler R.L., and Obrig T.G. Hemolytic-uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 17 (2002) 293-298
6. Cleary T.G. The role of Shiga toxin-producing Escherichia coli in hemorrhagic colitis and haemolytic-uremic syndrome. Semin Pediatr Infect Dis 15 (2004) 260-265
7. Moake J. Thrombotic microangiopathies. N Engl J Med 347 (2002) 589-600
8. Vermelen H.M., Karch H., Brandis M., and Zimmerhackl L.B. Enterohemorrhagic Escherichia coli infections: following transmission routes. Pediatr Nephrol 14 (2000) 73-83
9. Crump J., Sulka A., Langer A., Schaben C., Crielly A.S., Gage R., et al. An outbreak of Escherichia coli O157: H7 infections among visitors to a dairy farm. N Engl J Med 347 (2002) 555-560
10. Decludt B., Bouvet P., Mariani-Kurkdjian P., Grimont F., Grimont P.A., Hubert B., et al. Haemolytic-uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de nephrologie pediatrique. Epidemiol Infect 124 (2000) 215-220
11. Loirat C., Baudouin V., Sonsino E., et al. Hemolytic-uremic syndrome in the child. Adv Nephrol 22 (1993) 141-168
12. Siegler R. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr 125 (1994) 511-518
13. Loirat C., and Taylor C.M. Hemolytic-uremic syndromes. In: Avner E.D., Harmon W.E., and Niaudet P. (Eds). Pediatric Nephrology. 5th ed. (2003), Lippincott, Williams and Wilkins, Baltimore 887-915
14. Habib R. Pathology of the hemolytic and uremic syndrome. In: Kaplan B.S., Trompeter R., and Moake J. (Eds). Hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura (1992), Dekker, New York 315-353
15. Gerber A., Karch H., Allerberger F., and Verweyen H.M. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 186 (2002) 493-500
16. Loirat C., Sonsino E., Varga Moreno A., Pillion G., Mercier J.C., Beaufils F., et al. Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features. Acta Paediatr Scand 73 (1984) 505-514
17. Spizzirri F., Rahman R., Bibiloni N., Ruscasso J.D., and Amoreo ORl. Childhood haemolytic-uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 11 (1997) 156-160
18. Tönshoff B., Sammet A., Sanden I., Mehls O., Waldherr R., and Scharer K. Outcome and prognostic determinants in the haemolytic-uremic syndrome of children. Nephron 68 (1994) 63-70
19. Gagnadoux M.F., Habib R., Gubler M.C., Bacri J.L., and Broyer M. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome. Clin Nephrol 46 (1996) 39-41
20. Habib R., Levy M., Gagnadoux M.F., and Broyer M. Prognosis of the hemolyric-uremic syndrome in children. Adv Nephrol 11 (1982) 99-128
21. Kelles A., Van Dyck M., and Proesmans W. Childhood haemolytic uraemic syndrome: long-term outcome and prognostic features. Eur J Pediatr 153 (1994) 38-42
22. Trompeter R.S., Schwartz R., Chantler C., Dillon M.J., Haycock G.B., Kay R., et al. Haemolytic-uraemic syndrome: an analysis of prognostic features. Arch Dis Child 58 (1983) 101-105
23. Wong C.S., Jelacic S., Habeeb R.C., Watkins S.L., and Tarr Pl. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli 0157: H7 infections. N Engl J Med 342 (2000) 1930-1936
24. Smith M.J., Teel L.D., Carvalho H.M., Melton-Celsa A.R., and O'Brien A.D. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2. Vaccine 24 (2006) 4122-4129
25. Bhimma R., Rollins N.C., Coovadia H.M., and Adhikari M. Postdysenteric haemolytic-uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. Pediatr Nephrol 11 (1997) 560-564
26. Brandt J., Wong C., Mihm S., Roberts J., Smith J., Brewer E., et al. Invasive pneumococcal disease and haemolytic-uremic syndrome. Pediatrics 110 (2002) 366-371
27. Nathanson S., and Deschenes G. Prognosis of Streptococcus pneumoniae-induced haemolytic-uremic syndrome. Pediatr Nephrol 16 (2001) 362-365
28. Fitzpatrick M.M., Walters M.D., Trompeter R.S., Dillon M.J., and Barratt T.M. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. J Pediatr 122 (1993) 532-537
29. Neuhaus T.J., Calonder S., and Leumann E.P. Heterogeneity of atypical haemolytic-uremic syndromes. Arch Dis Child 76 (1997) 518-521
30. Caprioli J., Noris M., Brioschi S., Pianetti G., Castelletti F., Bettinaglio P., et al. International registry of recurrent and familial HUS/TTP. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108 (2006) 1267-1279
31. Dragon-Durey M.A., and Fremeaux-Bacchi V. Atypical haemolytic-uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 27 (2005) 359-374
32. Saunders R.E., Abarrategui-Garrido C., Fremeaux-Bacchi V., Goicoechea de Jorge E., Goodship T.H., Lopez Trascasa M., et al. The interactive factor H-atypical haemolytic-uremic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models. Hum Mutat 28 (2007) 222-234
33. Walport M.J. Complement. First of two parts. N Engl J med 344 (2001) 1058-1066
34. Warwicker P., Goodship T.H.J., Donne R.L., Pirson Y., Nicholls A., Ward R.M., et al. Genetic studies into haemolytic-uraemic syndrome. Kidney Int 53 (1998) 836-844
35. Warwicker P., Donne R.L., Goodship J.A., Goodship T.H., Howie A.J., Kumararatne D.S., et al. Familial relapsing haemolytic-uraemic syndrome and complement factor H deficiency. Nephrol Dial Transplant 14 (1999) 1229-1233
36. Buddles M.R., Donne R.L., Richards A., Goodship J., and Goodship T.H. Complement factor H gene mutation associated with autosomal recessive atypical haemolytic-uremic syndrome. Am J Hum Genet 66 (2000) 1721-1722
37. Caprioli J., Bettinaglio P., Zipfel P.F., Amadei B., Daina E., Gamba S., et al. Italian registry of familial and recurrent HUS/TTP. The molecular basis of familial haemolytic-uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 12 (2001) 297-307
38. Ohali M., Shalev H., Schlesinger M., Katz Y., Kachko L., Carmi R., et al. Hypocomplementemic autosomal recessive haemolytic-uremic syndrome with decreased factor H. Pediatr Nephrol 12 (1998) 619-624
39. Ying L., Katz Y., Schlesinger M., Carmi R., Shalev H., Haider N., et al. Complement factor H gene mutation associated with autosomal recessive atypical haemolytic-uremic syndrome. Am J Hum Genet 65 (1999) 1538-1546
40. Neumann H.P., Salzmann M., Bohnert-Iwan B., Mannuelian T., Skerka C., Lenk D., et al. Haemolytic-uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet 40 (2003) 676-681
41. Kavanagh D., Kemp E.J., Mayland E., Winney R.J., Duffield J.S., Warwick G., et al. Mutations in complement factor I predispose to development of atypical haemolytic-uremic syndrome. J Am Soc Nephrol 16 (2005) 2150-2155
42. Noris M., Brioschi S., Caprioli J., Todeschini M., Bresin E., Porrati F., et al. International registry of recurrent and familial HUS/TTP. Familial haemolytic-uraemic syndrome and an MCP mutation. Lancet 362 (2003) 1542-1547
43. Fremeaux-Bacchi V., Moulton E.A., Kavanagh D., Dragon-Durey M.A., Blouin J., Caudy A., et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical haemolytic-uremic syndrome. J Am Soc Nephrol 17 (2006) 2017-2025
44. Goicoechea de Jorge E., Harris C.L., Esparza-Gordillo J., Carreras L., Arranz E.A., Garrido C.A., et al. Gain-of-function mutations in complement factor B are associated with atypical haemolytic-uremic syndrome. Proc Natl Acad Sci USA 104 (2007) 240-245
45. Dragon-Durey M.A., Loirat C., Cloarec S., Macher M.A., Blouin J., Nivet H., et al. Anti-factor H autoantibodies associated with atypical haemolytic-uremic syndrome. J Am Soc Nephrol 16 (2005) 555-563
46. Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339 (1998) 1578-1584
47. Kokame K., Matsumoto M., Soejima K., Yagi H., Ishizashi H., Funato M., et al. Mutations and common polymorphisms in ADAMTS 13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci USA 99 (2002) 11902-11907
48. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413 (2001) 488-494
49. Tsai H., and Lian E. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339 (1998) 1585-1594
50. Veyradier A., Obert B., Haddad E., Cloarec S., Nivet H., Foulard M., et al. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical haemolytic-uremic syndrome. J Pediatr 142 (2003) 310-317
51. Deschenes G., Veyradier A., Cloarec S., Benoit S., Desbois I., Gruel Y., et al. Plasma therapy in von Willebrand factor-protease deficiency. Pediatr Nephrol 17 (2002) 867-870
52. Noris M., Bucchioni S., and Galbusera M. Complement factor H mutation. J Am Soc Nephrol 16 (2005) 1177
53. Kind T., Levy J., Lee M., Kaicker S., Nicholson J.F., and Kane S.A. Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. J Pediatr Hematol Oncol 24 (2002) 327-329
54. Niaudet P., Gagnadoux M., Broyer M., et al. Hemolytic-uremic syndrome: hereditary forms and forms associated with hereditary diseases. Adv Nephrol Necker Hosp 30 (2000) 261-280
55. Kaplan B., and Leonard M. Autosomal dominant haemolytic-uremic syndrome: variable phenotypes and transplant results. Pediatr Nephrol 14 (2000) 464-468
56. Kojouri K., Vesely S.K., and George J.N. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med 135 (2001) 1047-1051
57. Ferraris J.R., Ramirez J.A., Ruiz S., Caletti M.G., Vallejo G., Piantanida J.J., et al. Shiga toxin-associated haemolytic-uremic syndrome: absence of recurrence after renal transplantation. Pediatr Nephrol 17 (2002) 809-814
58. Ducloux D., Rebibou J.M., Sernhoun-Ducloux S., Jarnali M., Fournier V., Bresson-Vautrin C., et al. Recurrence of haemolytic-uremic syndrome in renal transplant recipients. Transplantation 65 (1998) 1405-1407
59. Bresin E., Daina E., Noris M., Castelletti F., Stefanov R., Hill P., et al., For the international registry of recurrent, familial HUS/TTP. Outcome of renal transplantation in patients with non Shiga toxin-associated haemolytic-uremic syndrome: prognostic significance of genetic backgroung. Clin J Am Soc Nephrol 1 (2006) 88-89
60. Loirat C., Sellier-Leclerc A.L., Dragon-Durey A., and Fremeaux-Bacchi V. Récidive du syndrome hémolytique et urémique après transplantation rénale: facteurs de risque, incidence et prognostic. Courrier de la Transplantation 3 (2006) 148-153
61. Loirat C., and Niaudet P. The risk of recurrence of haemolytic-uremic syndrome after renal transplantation in children. Pediatr Nephrol 18 (2003) 1095-1101